Heart Historical Balance Sheet

HSCS Stock

USD 2.96 0.05 1.72%

Trend analysis of Heart Test Laboratories balance sheet accounts such as Other Current Liabilities of 627.4 K or Total Current Liabilities of 2.1 M provides information on Heart Test's total assets, liabilities, and equity, which is the actual value of Heart Test Laboratories to its prevalent stockholders. By breaking down trends over time using Heart Test balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Heart Test Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heart Test Laboratories is a good buy for the upcoming year.

Heart Test Inventory

573,994

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Heart Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Heart Test Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Heart Test Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Heart Test and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Heart currently owns. An asset can also be divided into two categories, current and non-current.

Heart Test Balance Sheet Chart

At this time, Heart Test's Net Receivables is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 11.5 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 627.4 K in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of Heart Test assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Heart Test Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Heart Test balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Heart Test Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Heart Test's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Heart Test Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.6M	1.0M	932.7K	886.1K
Total Assets	3.3M	9.5M	10.9M	11.5M

Short Long Term Debt Total Total Assets

Heart Test balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.17	0.62	0.39	0.9	0.14	0.56	0.77	-0.85	-0.86	0.42	1.0	1.0	0.47	-0.09	1.0	0.99	-0.64	-0.21	0.68	-0.86	0.99	0.88	0.16	0.99	0.75
Short Long Term Debt Total	-0.17		0.61	0.77	-0.58	-0.99	-0.7	0.33	0.64	-0.11	0.59	-0.13	-0.26	0.59	0.99	-0.13	-0.27	-0.5	0.99	-0.5	-0.28	-0.13	-0.13	0.92	-0.25	-0.48
Other Current Liab	0.62	0.61		0.89	0.23	-0.59	0.06	0.94	-0.18	-0.83	0.88	0.65	0.54	0.92	0.63	0.65	0.56	-0.95	0.58	0.33	-0.92	0.67	0.66	0.79	0.54	0.37
Total Current Liabilities	0.39	0.77	0.89		-0.03	-0.79	-0.24	0.76	0.1	-0.6	0.92	0.43	0.31	0.71	0.76	0.43	0.31	-0.73	0.73	0.0	-0.72	0.42	0.38	0.92	0.31	0.05
Total Stockholder Equity	0.9	-0.58	0.23	-0.03		0.55	0.76	0.48	-0.99	-0.66	0.06	0.88	0.94	0.13	-0.5	0.88	0.94	-0.31	-0.61	0.76	-0.58	0.88	0.79	-0.28	0.93	0.82
Net Tangible Assets	0.14	-0.99	-0.59	-0.79	0.55		0.73	-0.32	-0.62	0.09	-0.57	0.1	0.23	-0.54	-0.99	0.1	0.24	0.47	-0.98	0.53	0.28	0.11	0.13	-0.92	0.21	0.5
Property Plant And Equipment Net	0.56	-0.7	0.06	-0.24	0.76	0.73		0.38	-0.83	-0.48	0.02	0.54	0.6	0.04	-0.7	0.54	0.64	-0.12	-0.71	0.96	-0.33	0.57	0.72	-0.54	0.58	0.95
Current Deferred Revenue	0.77	0.33	0.94	0.76	0.48	-0.32	0.38		-0.45	-0.91	0.8	0.79	0.71	0.84	0.36	0.79	0.73	-0.89	0.3	0.61	-0.95	0.81	0.87	0.54	0.7	0.65
Net Debt	-0.85	0.64	-0.18	0.1	-0.99	-0.62	-0.83	-0.45		0.65	-0.02	-0.83	-0.89	-0.11	0.58	-0.83	-0.9	0.26	0.67	-0.82	0.52	-0.83	-0.78	0.37	-0.88	-0.86
Retained Earnings	-0.86	-0.11	-0.83	-0.6	-0.66	0.09	-0.48	-0.91	0.65		-0.69	-0.88	-0.82	-0.77	-0.14	-0.88	-0.85	0.85	-0.08	-0.68	0.94	-0.9	-0.84	-0.39	-0.82	-0.7
Accounts Payable	0.42	0.59	0.88	0.92	0.06	-0.57	0.02	0.8	-0.02	-0.69		0.46	0.35	0.72	0.55	0.46	0.37	-0.76	0.56	0.25	-0.76	0.47	0.46	0.79	0.32	0.27
Cash	1.0	-0.13	0.65	0.43	0.88	0.1	0.54	0.79	-0.83	-0.88	0.46		0.99	0.51	-0.05	1.0	0.99	-0.67	-0.17	0.67	-0.88	1.0	0.89	0.2	0.99	0.75
Non Current Assets Total	1.0	-0.26	0.54	0.31	0.94	0.23	0.6	0.71	-0.89	-0.82	0.35	0.99		0.39	-0.18	0.99	1.0	-0.57	-0.3	0.7	-0.81	0.98	0.87	0.07	1.0	0.77
Non Currrent Assets Other	0.47	0.59	0.92	0.71	0.13	-0.54	0.04	0.84	-0.11	-0.77	0.72	0.51	0.39		0.62	0.51	0.43	-0.97	0.6	0.31	-0.82	0.55	0.56	0.69	0.4	0.31
Long Term Debt	-0.09	0.99	0.63	0.76	-0.5	-0.99	-0.7	0.36	0.58	-0.14	0.55	-0.05	-0.18	0.62		-0.05	-0.19	-0.55	0.98	-0.49	-0.34	-0.06	-0.08	0.92	-0.16	-0.45
Cash And Short Term Investments	1.0	-0.13	0.65	0.43	0.88	0.1	0.54	0.79	-0.83	-0.88	0.46	1.0	0.99	0.51	-0.05		0.99	-0.67	-0.17	0.67	-0.88	1.0	0.89	0.2	0.99	0.75
Net Receivables	0.99	-0.27	0.56	0.31	0.94	0.24	0.64	0.73	-0.9	-0.85	0.37	0.99	1.0	0.43	-0.19	0.99		-0.6	-0.3	0.74	-0.83	0.99	0.89	0.07	0.99	0.81
Common Stock Shares Outstanding	-0.64	-0.5	-0.95	-0.73	-0.31	0.47	-0.12	-0.89	0.26	0.85	-0.76	-0.67	-0.57	-0.97	-0.55	-0.67	-0.6		-0.5	-0.38	0.93	-0.71	-0.66	-0.69	-0.58	-0.41
Non Current Liabilities Total	-0.21	0.99	0.58	0.73	-0.61	-0.98	-0.71	0.3	0.67	-0.08	0.56	-0.17	-0.3	0.6	0.98	-0.17	-0.3	-0.5		-0.5	-0.26	-0.17	-0.17	0.9	-0.29	-0.49
Capital Lease Obligations	0.68	-0.5	0.33	0.0	0.76	0.53	0.96	0.61	-0.82	-0.68	0.25	0.67	0.7	0.31	-0.49	0.67	0.74	-0.38	-0.5		-0.55	0.71	0.85	-0.31	0.67	0.99
Inventory	-0.86	-0.28	-0.92	-0.72	-0.58	0.28	-0.33	-0.95	0.52	0.94	-0.76	-0.88	-0.81	-0.82	-0.34	-0.88	-0.83	0.93	-0.26	-0.55		-0.9	-0.83	-0.57	-0.81	-0.61
Other Current Assets	0.99	-0.13	0.67	0.42	0.88	0.11	0.57	0.81	-0.83	-0.9	0.47	1.0	0.98	0.55	-0.06	1.0	0.99	-0.71	-0.17	0.71	-0.9		0.9	0.2	0.98	0.77
Other Stockholder Equity	0.88	-0.13	0.66	0.38	0.79	0.13	0.72	0.87	-0.78	-0.84	0.46	0.89	0.87	0.56	-0.08	0.89	0.89	-0.66	-0.17	0.85	-0.83	0.9		0.09	0.87	0.9
Total Liab	0.16	0.92	0.79	0.92	-0.28	-0.92	-0.54	0.54	0.37	-0.39	0.79	0.2	0.07	0.69	0.92	0.2	0.07	-0.69	0.9	-0.31	-0.57	0.2	0.09		0.08	-0.26
Net Invested Capital	0.99	-0.25	0.54	0.31	0.93	0.21	0.58	0.7	-0.88	-0.82	0.32	0.99	1.0	0.4	-0.16	0.99	0.99	-0.58	-0.29	0.67	-0.81	0.98	0.87	0.08		0.75
Property Plant And Equipment Gross	0.75	-0.48	0.37	0.05	0.82	0.5	0.95	0.65	-0.86	-0.7	0.27	0.75	0.77	0.31	-0.45	0.75	0.81	-0.41	-0.49	0.99	-0.61	0.77	0.9	-0.26	0.75

Click cells to compare fundamentals

Heart Test Account Relationship Matchups

Heart Test balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.9M	2.1M	3.3M	9.5M	10.9M	11.5M
Short Long Term Debt Total	3.1M	6.2M	1.6M	1.0M	932.7K	886.1K
Other Current Liab	422.4K	1.1M	672.0K	701.3K	806.5K	627.4K
Total Current Liabilities	1.2M	3.5M	1.8M	1.8M	2.0M	2.1M
Total Stockholder Equity	(1.9M)	(6.1M)	230.6K	7.3M	8.4M	8.8M
Property Plant And Equipment Net	289.3K	158.6K	590.7K	560.0K	644.0K	443.6K
Net Debt	2.4M	5.2M	(94.6K)	(4.8M)	(4.3M)	(4.1M)
Retained Earnings	(49.6M)	(54.4M)	(60.8M)	(67.4M)	(60.6M)	(63.7M)
Accounts Payable	335.8K	694.7K	631.4K	448.2K	515.4K	543.2K
Cash	723.5K	918.3K	1.7M	5.8M	6.7M	7.0M
Non Current Assets Total	289.3K	158.6K	590.7K	2.1M	2.5M	2.6M
Cash And Short Term Investments	723.5K	918.3K	1.7M	5.8M	6.7M	7.0M
Net Receivables	94.8K	2.3K	319.4K	876.7K	1.0M	1.1M
Common Stock Shares Outstanding	33.1K	33.2K	79.5K	352.5K	317.3K	301.4K
Liabilities And Stockholders Equity	1.9M	2.1M	3.3M	9.5M	10.9M	11.5M
Non Current Liabilities Total	2.6M	4.7M	1.2M	434.0K	390.6K	371.1K
Capital Lease Obligations	198.6K	91.0K	565.9K	536.3K	616.8K	370.4K
Inventory	750.8K	674.1K	676.4K	629.2K	566.3K	574.0K
Other Current Assets	163.8K	89.8K	359.8K	917.1K	1.1M	1.1M
Other Stockholder Equity	47.7M	48.3M	61.0M	74.7M	85.9M	61.4M
Total Liab	3.8M	8.1M	3.1M	2.2M	2.5M	4.2M
Net Invested Capital	970.1K	15.5K	1.2M	7.8M	9.0M	9.4M
Property Plant And Equipment Gross	707.7K	603.5K	1.1M	1.1M	1.2M	932.4K
Total Current Assets	1.6M	1.9M	2.7M	7.4M	8.5M	8.9M
Capital Stock	3.8K	3.8K	10.5K	1.1K	1.2K	1.2K
Net Working Capital	392.0K	(1.5M)	863.7K	5.6M	6.4M	6.8M
Short Term Debt	487.8K	1.7M	529.5K	602.3K	692.6K	832.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heart Historical Balance Sheet

Heart Test Inventory

573,994

About Heart Balance Sheet Analysis

Heart Test Balance Sheet Chart

Total Assets

Total Current Liabilities

Heart Test balance sheet Correlations

Heart Test Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Heart Test balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Heart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Other Current Assets	+ 1.0	Cash
Net Receivables	+ 1.0	Non Current Assets Total

Long Term Debt	- 0.99	Net Tangible Assets
Net Debt	- 0.99	Total Stockholder Equity
Net Tangible Assets	- 0.99	Short Long Term Debt Total
Non Current Liabilities Total	- 0.98	Net Tangible Assets
Common Stock Shares Outstanding	- 0.97	Non Currrent Assets Other
Inventory	- 0.95	Current Deferred Revenue